Roche Diagnostics Says HPV, MRSA Molecular Tests Will Help Drive Near-Term Growth
July 22, 2010
Roche Diagnostics Says HPV, MRSA Molecular Tests Will Help Drive Near-Term Growth
The head of Roche Diagnostics today highlighted the company's PCR-based tests for human papillomavirus and methicillin-resistant Staphylococcus aureus as potential key drivers of expected continued growth in the coming year of the company's diagnostics business.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Gen-Probe Sees Specificity of Newly Approved HPV Test as Market Differentiator
November 3, 2011 / PCR Insider - Rheonix Presents Data to Back Flagship MDx Platform; Maps Regulatory Timeline for Two Tests
August 5, 2010 / PCR Insider - Qiagen, BioBay Open Translational Medicine Center in China
May 24, 2013 / GenomeWeb Daily News - DxNA Licenses Staph Assay from PathoGene for Use on GeneStat System
May 9, 2013 / PCR Insider - Molecular Diagnostics Lifts Qiagen's Q1 Revenues 2 Percent
April 30, 2013 / GenomeWeb Daily News